It confirmed a diagnosis of hypereosinophilic syndrome with the FIP1L1‐PDGFRA fusion gene, indicating myeloid neoplasm with eosinophilia and PDGFR-A rearrangement. The gene discussed is FIP1L1; the disease is hypereosinophilic syndrome.